Note 4 - Going Concern |
12 Months Ended |
|---|---|
Dec. 31, 2017 | |
| Notes | |
| Note 4 - Going Concern | NOTE 4. GOING CONCERN
The accompanying Consolidated Financial Statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has suffered recurring losses, negative working capital and is dependent upon raising capital to continue operations. The Company has incurred losses resulting in an accumulated deficit of $12,483,577 and $11,714,186 as of December 31, 2017 and 2016, respectively.
The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. It is managements plan to generate additional working capital by increasing revenue resulting in new sales and marketing initiatives and by raising additional capital from investors.
Management's plans with regards to these issues are as follows:
· Raising new investment capital in the form of loans and the sale of shares of the companys stock, sufficient to invest in theater operations improvements that will result in continual quarterly revenue growth until revenues are sufficient to meet operating expenses on an ongoing basis.
· Maintaining the Company mission of focusing on net profits by increasing ticket sales and introducing concession items with higher gross profit.
· Achieving on-going breakeven revenue and expenses by the middle of 2018 based on: 1) current management assumptions, 2) Hollywood film release performance, and 3) increased attendance resulting from marketing and physical theater improvements.
The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually attain profitable operations.
The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. |